Fundz

Globus Medical

Audubon, Pennsylvania, United States · Biotechnology, Health Care, Manufacturing

Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Key facts

Headquarters
Audubon, Pennsylvania, United States
Employees
2,967
Industries
Biotechnology, Health Care, Manufacturing
Status
Public (GMED)
Website
www.globusmedical.com
LinkedIn
Company page

Recent activity at Globus Medical

  • : Globus Medical acquires Higgs Boson Health
  • : SEC 8-K (5.02): On June 3, 2026, Globus Medical, Inc. held its 2026 Annual Meeting of Stockholders where stockholders approved the 2021 Equity Incentive Plan Amendment, increasing the number of shares authorized under the plan by 1,000,000 shares to a total of 12,000,000 shares of Class A Common Stock. This amendment was originally recommended and approved by the Compensation Committee and the Board, contingent on stockholder approval during the meeting. The amendment became effective immediately upon approval. Additionally, during the meeting, stockholders elected two Class II directors, Keith W. Pfeil and Robert A. Douglas, each for a three-year term, with significant vote counts in their favor. This strategic move aims to enhance the company's ability to incentivize employees and drive growth potential.
  • : SEC 8-K (5.02): On June 3, 2026, Globus Medical, Inc. held its 2026 Annual Meeting of Stockholders where the stockholders approved an amendment to the 2021 Equity Incentive Plan, increasing the number of shares authorized by 1,000,000. This amendment was previously recommended by the Compensation Committee and approved by the Board of Directors, contingent on stockholder approval. The approval of this amendment enhances the Company’s ability to incentivize and retain key employees, which could positively impact its operational performance and growth strategies moving forward.
  • : SEC 8-K (5.02): On March 23, 2026, John A. DeFord, Ph.D., a member of the Board of Directors of Globus Medical, Inc., resigned from his position effective immediately. His resignation was not due to any disagreements with the company, indicating a smooth transition. The decision was communicated through a press release issued by the Company on the same date. This change in the Board may have implications for the company's governance and strategic decisions moving forward.
  • : SEC 8-K (5.02): On March 23, 2026, John A. DeFord, Ph.D., a member of the Board of Directors of Globus Medical, Inc., resigned from the Board effective immediately. His resignation was not due to any disagreements with the Company, indicating a smooth transition. The Company subsequently issued a press release on the same date announcing this change. This departure potentially allows for new strategic leadership within the Board, although no specific financial implications were mentioned.
  • : SEC 8-K (2.02): On February 24, 2026, Globus Medical, Inc. released its sales and operating results for the three and twelve-month periods ended December 31, 2025. This report highlights the financial performance of the company, including total sales figures, net income, and other key operational metrics. The press release provides valuable insights into the company's performance in the previous fiscal year, indicating trends that could affect investor perspectives and business strategies moving forward. This event is significant as it informs shareholders of the company's financial health and operational success.
  • : Globus Medical completes acquisition of Nevro Corp.
  • : Globus Medical, Inc. launches the COHERE™ ALIF Spacer and Modulus™ ALIF Blades, enhancing anterior interbody surgical procedures.
  • : Globus Medical, Inc. Launches ExcelsiusHub™ Navigation System to Enhance Spine Surgery Precision.
  • : Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

Leadership

  • Aaron Swanson, Vice President, MERC, Surgeon and Physician Development
  • Lisandra Abreu, Senior Talent Acquisition Partner - EMEA
  • Talmage Holt, Medical Device Sales Professional (Senior Spine Specialist)
  • Guido Fratoni, Regional Sales Manager
  • Judd Laurie, Sr. Clinical Neurophysiologist
  • Jeffrey Cohen, Chief Compliance Officer
  • Daniel Scavilla, President
  • Keith Pfeil, Chief Operating Officer

Verified email and direct lines for Globus Medical’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Globus Medical files 4 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Globus Medical in the news

Companies similar to Globus Medical

About Globus Medical: questions and answers

What does Globus Medical do?

Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Where is Globus Medical headquartered?

Globus Medical is headquartered in Audubon, Pennsylvania, United States.

How many employees does Globus Medical have?

Globus Medical has about 2,967 employees.

Who leads Globus Medical?

Aaron Swanson is a Vice President, MERC, Surgeon and Physician Development at Globus Medical.

What is the latest news on Globus Medical?

On Aug 26, 2026, Globus Medical acquires Higgs Boson Health

Is Globus Medical a public company?

Yes. Globus Medical is publicly traded under the ticker GMED.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Globus Medical across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.